Identification of prognostic genes related to T cell proliferation in papillary thyroid cancer based on single-cell RNA sequencing and bulk RNA sequencing data.

Journal: Clinical and experimental medicine
Published Date:

Abstract

Papillary thyroid carcinoma (PTC) is the main pathological subtype of thyroid cancer. Given the strong association between T cells and PTC, this study focused on the prognostic value and potential molecular mechanisms of T cell proliferation-related genes (TPRGs) in PTC. ScRNA-seq data were analyzed to identify key cells and subpopulations based on public databases. Candidate genes were determined by intersecting differentially expressed genes (DEGs) from differential expression analysis of key subpopulations, high- and low-TPRGs score groups, and bulk RNA-seq data. Prognostic genes were then determined via Cox regression and a machine learning algorithm. A risk model was formed. PTC patients were grouped into high-risk and low-risk groups by risk score. Subsequently, the immune microenvironment was analyzed. Finally, cell communication analysis and pseudotime analysis were accomplished. T/NK cells were selected as key cells. Moreover, CD4 memory cells were selected as the key subpopulation. Meanwhile, KLRB1, TSHZ2, and TRABD2A were spotted as prognostic genes. The risk model had better prognostic value. Additionally, 5 DICs were spotted in two risk groups. Besides, the scores of IPS-CTLA4 and PD-L1 blocker, IPS-CTLA4 blocker, and IPS-PD-1 blocker were lower in the HRG group. In addition, the most substantial receptor-ligand interaction in T/NK cells was found to be CLEC2C-KLRB1. Moreover, as T/NK cells differentiated, the expression level of KLRB1 was observed to rise slowly at first and then decline rapidly. KLRB1, TSHZ2, and TRABD2A were spotted as prognostic genes, providing new PTC prognosis and treatment strategies.

Authors

  • Qingkai Meng
    Department of Colorectal Surgery, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Hongzhu Liu
    School of Medical Imaging, Binzhou Medical University, Yantai, 264003, Shandong, China.
  • Mengtong Wang
    Shandong Second Medical University, Weifang, 264000, Shandong, China.
  • Xin Jiang
    Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, People's Republic of China.
  • Yi Wang
    Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Xiaoli Cao
    Department of Ultrasound Medicine, Yantai Yuhuangding Hospital, Yantai, 264000, Shandong, China. xiaolicao969@163.com.
  • Nina Qu
    Department of Ultrasound, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, China.